PLK1 and neoplasm: We are aware that additional independent cohorts of early-stage OC patients, including endometroid, mucinous, and mixed tumor subtypes, need to be analyzed before a clinical use of cDNA arrays for the determination of Ki-67 and Plk1 levels can be recommended.